-
Announcement of China Biological Fermentation Industry Association on approving and issuing the group standard of "Probiotic Products, Lactic Acid Bacteria Postbiotics
Time of Update: 2023-02-01
In accordance with the requirements of the "China Biological Fermentation Industry Association Group Standard Revision Work Procedure", the group standard of "Probiotic Products Lactic Acid Bacteria Metabiotics" reviewed and approved by the association is hereby published.
Attachment: List of group standard numbers, names, main contents, etc China Biological Fermentation Industry Association January 9, 2023
-
The growth rate of the four varieties exceeds 100
Time of Update: 2021-09-18
According to MENET data, in 2020, the amount of anti-tumor small molecule targeted drugs in public hospitals in key provinces and cities in China will be nearly 15 billion yuan, an increase of 11.
-
Hengrui's 2020 financial report: revenue of 27.7 billion oncology drugs contributes 55% and PD-1 triples
Time of Update: 2021-05-10
Hengrui passed the consistency evaluation of the number of varieties and the bidding situation of centralized procurement A number of innovative drugs have started international multi-center phase III clinical trials In terms of internationalization, Hengrui will continue to increase the implementation of its internationalization strategy in 2020 and actively expand overseas markets.
-
Puli Pharmaceuticals injects vancomycin hydrochloric acid for injection is licensed to be listed in Canada
Time of Update: 2020-07-30
Guide: Vancomycin hydrochloric acid is used to treat serious infections caused by sensitive strains of methicillin-resistant staphylococcus.
approved indications: vancomycin hydrochloric acid is used to treat serious infections caused by the sensitive strains of methicillin-resistant staphylococcus ( beta-lactame).
-
Ask the pinnacle! An overview of the research and development pipeline of the anti-tumor drug I-Goroche Pharmaceuticals
Time of Update: 2020-07-20
Guide: Roche's research and development pipeline focuses on the field of oncology, combined with the future treatment needs of patients, continuous research and development investment, in the existing
-
State Drug Administration: Interim Measures for the Administration of Medical Supplies for Basic Medical Insurance
Time of Update: 2020-06-26
Guide: Deepen the reform of high-value medical supplies, improve the use of medical insurance funds, improve the level of medical supplies guarantee for basic medical insurance On June 8, , the State
-
Keystone Pharmaceuticals CS1001 Joint BLU-554 (CS3008) therapy approved for clinical trials in China
Time of Update: 2020-06-09
recently, Cornerstone Pharmaceuticals (Suzhou) Limited Company (http:// announced that its CS1001 joint BLU-554 (CS3008) therapy for the treatment of localized advanced or metastatic hepatocellul
-
The new paper reveals the current status of fecal transplantation in the treatment of various human diseases
Time of Update: 2020-02-19
In recent years, many researchers have carried out fecal microbial transplantation (FMT, fecal microbiota) Transplants) has conducted a large number of studies to determine whether it can improve the
-
The first oral medication for secondary progressive multiple sclerosis (SPMS)! Mayzent, a new generation of S1P receptor modulator of Novartis, has been approved by the European Union
Time of Update: 2020-01-22
January 22, 2020 / BIOON / -- Novartis, a Swiss pharmaceutical giant Novartis recently announced that the European Commission (EC) has approved mayzent (siponimod) for the treatment of adult patients
-
Medical and health industry weekly (November 4-8
Time of Update: 2019-11-10
Jointly released by: Sina pharmaceutical, CCID Consultant This week, a total of 6 drafts were released, including guiding principles for drafting pharmacovigilance entrustment agreement (Draft for com
-
Summary of 105 drugs passing conformity assessment
Time of Update: 2018-11-02
It is far from the last two months of 2018, and the progress of "289 catalog" variety consistency evaluation is far from the required goal to be completed by the end of 2018 According to the statistic
-
How to treat the "strategic abandonment" of multinational pharmaceutical enterprises to research projects
Time of Update: 2016-07-01
Source: Bio exploration 2016-06-30 how to select excellent new drug varieties suitable for the enterprise's own conditions has always been a matter of great concern for multinational pharmaceutical en
-
Janssen was fined more than $1.6 billion by the United States for over marketing of risperidone
Time of Update: 2013-11-07
Source: DXY on November 4, 2013, the U.S Department of justice, on behalf of the U.S Food and Drug Administration (FDA), announced a plea agreement with Janssen Pharmaceutical Company (JPI), based in
-
In 2011, 30 new drugs in the United States were approved, reaching a 7-year high
Time of Update: 2012-01-16
Source: Bloomberg News Agency 2012-01-16 in 2011, with pharmaceutical companies responding positively to regulatory requirements for more safety data, and trying to avoid FDA's "supplement" at the las
-
Four patents of AIDS drugs of Gilead
Time of Update: 2011-07-28
Source: Daily Economic News July 28, 2011 Gilead, the world's largest manufacturer of AIDS drugs, recently announced that it would put four drugs for AIDS treatment into the independent Swiss fund MPP
